UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreWinter/Spring 2022 Myeloma Magazine
The goal of Myeloma is to provide timely updates about progress in clinical treatment and research advances, as well as stories and information of general interest.
Read MagazineMyeloma Center: Myeloma Center Social Worker Receives Prestigious Certification
Jael Hastings, MSW, LCSW, a University of Arkansas for Medical Sciences (UAMS) Myeloma Center oncology social worker, recently reached a major career milestone, earning her Oncology Social Worker – Certified (OSW-C) certification. “When I learned that I had obtained the OSW-C certification I was very excited,” Hastings said. “My supervisor, Harold Dean, shared information about…
News & Announcements
Denver Broncos Defensive Tackle D.J. Jones Highlights UAMS Myeloma Center in My Cause, My Cleats Campaign
As part of the National Football League’s (NFL) annual My Cause, My Cleats campaign, Denver Broncos defensive tackle D.J. Jones donated a pair of custom cleats to the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute. Since 2016, participating NFL teams and players customize footwear with designs…
Read more
Myeloma Patient Celebrates Full Remission by Walking Daughter Down the Aisle
Dave Puente of Elk Grove California, the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) last November, recently saw a very personal goal he’d set for himself become a reality. Late last year, during an interview for an article…
Read more
Study Puts More Than 50 UAMS Faculty Among Top 2% of Influential Researchers
LITTLE ROCK — A study by Stanford University lists over 50 current and retired UAMS faculty among the top 2% of most influential researchers. The study is based on an analysis of Scopus, the largest database of peer-reviewed research literature. To determine the most influential researchers, the study authors used a combination of citation metrics…
Read more
Danyelle Musselman to Emcee UAMS Winthrop P. Rockefeller Cancer Institute’s ‘Be a Part of the Cure’ Walk on April 30
On April 30, the first lady of Arkansas Razorback Men’s Basketball, Danyelle Musselman, will emcee the UAMS Winthrop P. Rockefeller Cancer Institute’s “Be a Part of the Cure” Walk honoring all Arkansas cancer patients.
Read moreWant to read more stories like these?